Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Phenomenex SecurityGuard™ Cartridge System
Saturday, November 22, 2014
The cartridge system protects all non-aqueous gel permeation chromatography (GPC) column.

Super Sensitive Binning Results and Large Blot/Gel Capacity
Saturday, November 22, 2014
Makes Syngene’s G:BOXChemi XRQ a winner at major European University.

Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
Friday, November 21, 2014
exVive3D™ human liver tissue for preclinical drug discovery testing.

New Whitepaper from Malvern Instruments
Friday, November 21, 2014
Explores how Malvern extends a QbD approach to instrument design.

New Interfacing Options for Ultra Fast Framing Camera
Friday, November 21, 2014
Specialised imaging has announced a new version of its popular SIM Ultra Fast Framing Camera that includes an integral auxilary port enabling the system to be interfaced with high speed video, streak cameras, mass spectrometers or time resolved spectrometers.

SIMS Surface Analyzers with Potential
Thursday, November 20, 2014
A versatile, highly sensitive technique for compositional analysis of surfaces.

KNF’s RC900 Rotary Evaporator Proves Popular at Oxford
Thursday, November 20, 2014
System is designed to make attaching and detaching the round bottom flask simple.

Rapid and Reliable Detection of Dissolved Gases in Water
Thursday, November 20, 2014
Detection of dissolved gases in water using a gas chromatograph equipped with an autosampler.

Merck Millipore Launches Kit for Analyzing NF?B Translocation
Thursday, November 20, 2014
Permits quantitative, statistically robust assessment of NF?B translocation.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10671
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv